RSV Conference
21-22 November 2024.
Concluded Successfully

Bridging the Gap and Fostering Collaboration for Better Prevention and Treatment

Concluded Successfully

RSV Conference - learnengagenetwork

Respiratory Syncytial Virus “RSV” continues to significantly burden global healthcare systems, not for infant, but also for adults. RSV Conference offer a platform that gather researchers, clinicians, and healthcare professionals to network, exchange ideas, and present the latest on prevention, diagnosis and treatment, to improve health outcomes.

Thursday - 21 Nov
Friday - 22 Nov

The Discovery of RSV: A Historical Perspective

Dr. Abeer Migdad

Neonatologist

09:10

Virology of RSV: Structure and Function

Prof. Fahad Alzamil

Professor and Consultant Pediatric Infectious Disease

Virology of RSV: Structure and Function

09:35

Evolution of RSV: Genetic Diversity and Implications

Dr. Esam Albinayan

10:00

RSV, a New Era

Dr. Abdullah Asiri

The Assistant Deputy Minister for Preventive Health, Ministry Of Health

RSV, a New Era

10:45

Burden of RSV: Epidemiological Trends and Data

Prof. Abdullah Alshamrani

Pediatric Pulmonologist & Sleep Physician

Burden of RSV: Epidemiological Trends and Data

11:10

Seasonality of RSV: Patterns and Predictors

Prof. AbdulRahman Alnemri

Professor of Pediatric, College of Medicine KSU & KSUMC, Senior Consultant Neonatologist, President of Saudi Neonatology Society SNS

Seasonality of RSV: Patterns and Predictors

11:35

RSV Hospitalizations: Impact on Pediatric Populations

Dr. Abdullah Yousef

Pediatric Pulmonologist

RSV Hospitalizations: Impact on Pediatric Populations

12:00

Socioeconomic Impact of RSV

Dr. Saleh Alharbi

Pediatric Pulmonologist

Socioeconomic Impact of RSV

01:30

Current Approaches to RSV Diagnosis: Tools and Techniques

Dr. Raidan Alyazidi

Assistant Professor of Pediatrics and Infectious Disease

Current Approaches to RSV Diagnosis: Tools and Techniques

01:55

Managing RSV in Pediatric Emergency Settings: Best Practices

Dr. Saleh Alshehri

Consultant Pediatrician and ERM Physician

Managing RSV in Pediatric Emergency Settings: Best Practices

02:20

RSV Management in Hospitalized Adults: Clinical Guidelines and Challenges

Dr. Majed Alshamrani

Consultant, Executive Director, Infection Prevention and Control Program Institution

RSV Management in Hospitalized Adults: Clinical Guidelines and Challenges

03:15

RSV Guidelines and Best Practices: SIBRO 2024 Current Recommendations

Prof. Adel Alharbi

Pediatric Pulmoologist

RSV Guidelines and Best Practices: SIBRO 2024 Current Recommendations

03:40

A Quarter of a Century of RSV Prevention: Global Impact on Pediatric RSV

Dr Barry Rodgers-Gray

A Quarter of a Century of RSV Prevention: Global Impact on Pediatric RSV

04:05

Analyzing the RSV Landscape in KSA

Dr. Ali Almudeer

Neonatologist, MOH | NICU Lead, KSA

Analyzing the RSV Landscape in KSA

RSV Burden in Older Adults and Co Morbid Patients

Dr. Gawaher Alotaibi

RSV Burden in Older Adults and Co Morbid Patients

10:15

RSV Recommendation and the Value of Adjuvanted Vaccine

Dr. Riyad Allehebi

Pulmonologist & Sleep Physician

RSV Recommendation and the Value of Adjuvanted Vaccine

10:45

Global Insights on Implementation of RSV Prevention

Prof. William Joseph Muller

Professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine, Attending Physician, Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital of Chicago

01:55

RSV in Infants and Young Children: Risk Factors and Management

Dr. Turki Alahmadi

Pediatric Pulmonologist, King Abdulaziz University Hospital, Jeddah

02:20

Adult RSV: Emerging Concerns and Clinical Approaches

Dr. Ali Albarrak

Consultant Infectious Disease, Prince Sultan Military Medical City

02:45

RSV Prevention: Clinical Perspectives on Long-Acting Monoclonal Antibodies

Prof. William Joseph Muller

Professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine, Attending Physician, Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital of Chicago

RSV Prevention: Clinical Perspectives on Long-Acting Monoclonal Antibodies

03:10

Infant Protection through RSV Maternal Vaccines: RSV pre F Vaccine Clinical Data and RWE

Dr Mona Eldabbagh

Infant Protection through RSV Maternal Vaccines: RSV pre F Vaccine Clinical Data and RWE

03:55

RSV pre F bivalent vaccine in Older Adult Protection from RSV: Renoir Trial

Dr Hussam jnaid

RSV pre F bivalent vaccine in Older Adult Protection from RSV: Renoir Trial

04:20

Long-Term Sequelae of RSV: Impacts on Health Across the Lifespan

Dr Barry Rodgers-Gray

Long-Term Sequelae of RSV: Impacts on Health Across the Lifespan

05:25

RSV Vaccination: A Key to Protecting the General Population

Dr. Fayssal Farahat

Director Community and Public Health Infection Prevention and Control Program King Abdulaziz Medical City Ministry of National Guard Health Affairs, KSA

RSV Vaccination: A Key to Protecting the General Population

06:15

Recent Updates in RSV Recommendation: Focus on Saudi Arabia

Dr. Omar Khojah

Consultant Physician, Preventive Medicine and Public Health Director of Vaccine-Preventable Disease (VPDs) Department, Public Health Authority Executive Secretary, Immunization Technical Advisory Group, Public Health Authority

Recent Updates in RSV Recommendation: Focus on Saudi Arabia